Evidence map›Paper›PMID 36339224›Full record

ArticleFrontiers in public health2022

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China.

Wen Zeng, Ning Liu, Yuchun Li, Ai Gao, Mengyi Yuan, Rui Ma, Na Jiang, Dingwei Sun, Guangze Wang, Xinyu Feng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Wen ZengDepartment of Tropic Disease, Hainan Center for Disease Control and Prevention, Haikou, China.
Ning LiuDepartment of Gastrointestinal Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Yuchun LiDepartment of Tropic Disease, Hainan Center for Disease Control and Prevention, Haikou, China.
Ai GaoDepartment of Biology, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Mengyi YuanDepartment of Biology, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Rui MaDepartment of Biology, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Na JiangDepartment of Biology, College of Life Sciences, Inner Mongolia University, Hohhot, China.
Dingwei SunDepartment of Tropic Disease, Hainan Center for Disease Control and Prevention, Haikou, China.
Guangze WangDepartment of Tropic Disease, Hainan Center for Disease Control and Prevention, Haikou, China.
Xinyu FengNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Fudan University, Shanghai, China.
Hainan Center for Disease Control & Prevention · CNInner Mongolia University · CNHainan General Hospital · CNNational Institute for Parasitic Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primaquine, the only licensed antimalarial drug for eradication of

Indexed as

Glucosephosphate Dehydrogenase DeficiencyMalariaChinaEthnicityFemaleHumansMaleMinority GroupsPrevalencePrimaquinePrimaquineG6PDprevalenceprimaquinespatial clustervivax malaria

Identifiers

PMID36339224
PMCPMC9634581
OpenAlexW4307165658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.